NASDAQ:PETQPetIQ Stock Price, Forecast & News

PetIQ's stock was trading at $22.59 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, PETQ shares have increased by 54.7% and is now trading at $34.94. View which stocks have been most impacted by Coronavirus.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for PetIQ in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for PetIQ.

PetIQ is scheduled to release its next quarterly earnings announcement on Wednesday, August 5th 2020. View our earnings forecast for PetIQ.

PetIQ Inc (NASDAQ:PETQ) posted its quarterly earnings results on Thursday, May, 7th. The company reported $0.19 EPS for the quarter, beating the consensus estimate of $0.17 by $0.02. The company had revenue of $186.78 million for the quarter, compared to analyst estimates of $176.52 million. PetIQ had a positive return on equity of 8.28% and a negative net margin of 2.03%. View PetIQ's earnings history.

4 Wall Street analysts have issued twelve-month price objectives for PetIQ's shares. Their forecasts range from $35.00 to $44.00. On average, they expect PetIQ's stock price to reach $40.00 in the next twelve months. This suggests a possible upside of 14.5% from the stock's current price. View analysts' price targets for PetIQ.

Media coverage about PETQ stock has trended very negative this week, according to InfoTrie Sentiment Analysis. The research group identifies positive and negative media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. PetIQ earned a daily sentiment score of -3.2 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the next several days. View the latest news about PetIQ.

Some companies that are related to PetIQ include McKesson (MCK), AmerisourceBergen (ABC), Cardinal Health (CAH), Herbalife Nutrition (HLF), Nu Skin Enterprises (NUS), Trxade Group (TRXD), MultiCell Technologies (MEDS) and biOasis Technologies (BIOAF). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other PetIQ investors own include NVIDIA (NVDA), Micron Technology (MU), Alibaba Group (BABA), Intel (INTC), Advanced Micro Devices (AMD), CVS Health (CVS), Exelixis (EXEL), salesforce.com (CRM), Crispr Therapeutics (CRSP) and IBM (IBM).

(PETQ) raised $86 million in an IPO on Friday, July 21st 2017. The company issued 5,700,000 shares at a price of $14.00-$16.00 per share. Jefferies and William Blair served as the underwriters for the IPO and Oppenheimer, Raymond James and SunTrust Robinson Humphrey were co-managers.

PetIQ trades on the NASDAQ under the ticker symbol "PETQ."

PetIQ's stock is owned by a number of retail and institutional investors. Top institutional investors include Riverbridge Partners LLC (2.36%), Envestnet Asset Management Inc. (0.11%) and Xcel Wealth Management LLC (0.02%). Company insiders that own PetIQ stock include Ecp Helios Partners Iv, LP, James Nathan Clarke, John Newland, Mccord Christensen, Robert Michael Herrman, Susan Sholtis and Will Santana. View institutional ownership trends for PetIQ.

PETQ stock was purchased by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, Envestnet Asset Management Inc., and Xcel Wealth Management LLC. Company insiders that have bought PetIQ stock in the last two years include James Nathan Clarke, John Newland, and Robert Michael Herrman. View insider buying and selling activity for PetIQ.

Shares of PETQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of PETQ stock can currently be purchased for approximately $34.94.

PetIQ has a market capitalization of $991.60 million and generates $709.43 million in revenue each year. The company earns $-11,450,000.00 in net income (profit) each year or $1.07 on an earnings per share basis. PetIQ employs 1,866 workers across the globe.

The official website for PetIQ is www.petiq.com.

PetIQ's mailing address is 923 S. Bridgeway Pl., EAGLE ID, 83616. The company can be reached via phone at 208-939-8900 or via email at [email protected]